Ask the expert: Hormone receptor-positive breast cancer

Understanding Clinical Trial Eligibility for Cancer PatientsПодробнее

Bone Health, Menopause, and Hormone Replacement Therapy for Breast Cancer SurvivorsПодробнее

Exploring the Latest in Breast Cancer Treatments: SERDs, Mutations, and Precision MedicineПодробнее

when to consider reconstruction after a breast cancer diagnosisПодробнее

CDK4/6 for HR+ early breast cancer: monarchE resultsПодробнее

SABCS 2022: New breast cancer treatmentsПодробнее

What is HER2 low in breast cancer?Подробнее

Endocrine therapy benefits for stage 1 breast cancerПодробнее

Promising Clinical Trials and Research for Metastatic Breast Cancer in 2024Подробнее

Defining Endocrine therapy for Early Breast cancer patientsПодробнее

Ask the expert: Updates from the 2023 San Antonio Breast Cancer Symposium (SABCS)Подробнее

How to Treat Triple Positive Breast Cancer: All You Need to KnowПодробнее

Ask the expert: Updates from the 2023 San Antonio Breast Cancer SymposiumПодробнее

Ask the Experts | 2023 COEDS Discussion Series Fort LauderdaleПодробнее

Breast Cancer: Whether to pause Hormone Therapy for PregnancyПодробнее

Ask the expert: Triple-negative breast cancerПодробнее

Ask the Expert Webcast - Menopause it's more than a hot flush! with Dr Tonia MezziniПодробнее

Ask the Expert: Understanding the Latest Advances in Breast CancerПодробнее

Ask the Experts - Surgery, Oncology, and Movement ExpertsПодробнее

ASCO 2023 Expert Report in HR positive, HER2 negative breast cancer by Catherine Harper-WynneПодробнее